Nanotherapeutics Company Overview

Nanotherapeutics Inc. is an emerging specialty pharmaceutical company with expertise in the early-stage development of pharmaceuticals. The company employs several platform technologies to manipulate and enhance the properties of drugs. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.

Significant advances have been made in the area of nanometer-scale particle delivery and Nanotherapeutics has created three proprietary drug delivery technologies: NanoQUAD™, NanoDRY™, and NanoCOAT™. These specialized proprietary techniques can improve the release rate and enhance both the rate and extent of drug uptake, thus increasing bioavailability. The consequences of these changes include more consistent drug therapy with potentially reduced dose and dose frequency requirements and fewer side effects.

Our specialized powder processing techniques set us apart from most drug delivery companies. Other pharmaceutical advantages of the technologies include:

• Broad applicability - Our delivery options are applicable to a diverse group of drug molecules - proteins, peptides and other poorly absorbed compounds.
  
  

• Versatility of formulation - We have created various types of injectable, inhaled and oral formulations using our particle-based delivery expertise.
  
  

• Stabilization - We have demonstrated more than twelve months of room temperature stability with different formulations - including proteins - without loss of activity or dispersability.
  
  

• Ease of Manufacture - Scale-up to commercial quantities of production is readily obtainable at cost-effective levels.